Join to view full profile
4510 Executive DrSan Diego, CA 92121
Phone+1 858-657-8540
Fax+1 619-543-6806
Dr. Konersman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2010 - 2011- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2007 - 2010
Drexel University College of Medicine/Hahnemann University HospitalInternship, Internal Medicine, 2006 - 2007- Drexel University College of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2007 - 2027
WI State Medical License 2011 - 2015
PA State Medical License 2006 - 2007
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Neuromuscular Medicine
American Board of Electrodiagnostic MedicineAmerican Board of Electrodiagnostic Medicine
Awards, Honors, & Recognition
- Neurology Faculty Teaching Award Medical College of Wisconsin, 2014
- Neurology Faculty Resident Teaching Award UC San Diego, 2014
- Outstanding Medical Student Teacher Award Medical College of Wisconsin, 2013-2014
Publications & Presentations
PubMed
- Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.Craig M McDonald, Chet Villa, Jonathan H Soslow, Kati Maharry, Nathaniel Hogan
Lancet. 2026-08-22 - Longitudinal Psychometric Properties of the Myotonic Dystrophy Health Index in a Large Multicenter Cohort of People Living With Myotonic Dystrophy Type 1.Valeria A Sansone, Andrea Lizio, Carola R Ferrari Aggradi, Lucia C Greco, Cynthia Gagnon
Muscle & Nerve. 2026-07-01 - 3 citationsOnasemnogene abeparvovec gene therapy for treatment of patients with spinal muscular atrophy: Updated real-world practical considerations.Crystal M Proud, Elizabeth A Kichula, Susan E Matesanz, Ashutosh Kumar, Kayoko Saito
Journal of Neuromuscular Diseases. 2026-07-01
Professional Memberships
- Member
- World Muscle SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
